fda glp-1 compounding enforcement news october 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA's GLP-1 decision kicks off

Thats why we need more pharmacologic options to be used alongside lifestyle. With limited data on the use of GLP-1RAs in pediatric MASLD, Tou and mentor, Jennifer Panganiban, MD, attending gastroenterologist and director of the Non Alcoholic Fatty Liver Disease Program at Children's Hospital of Philadelphia, conducted a retrospective cohort study of patients aged younger than 21 years who started treatment with GLP-1RAs at Childrens Hospital of Philadelphia from Jan

L-carnitine: Heart Disease's Chemical Culprit

Commercial and Clinical-Grade Peptide Manufacturers Commercial manufacturers, often called CDMOs, sit in a different tier

Tesamorelin helps break down fat and improve how the body manages fat storage

Semaglutide, a Glucagon Like Peptide-1 Receptor Agonist With Cardiovascular Benefits for Management of Type 2 Diabetes